Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	200.07	267.77	440.93	66.43	25.78	54.72
Cash & Short-Term Investments	200.07	267.77	440.93	66.43	25.78	54.72
Cash Growth	-39.17%	-39.27%	563.78%	157.71%	-52.89%	-
Accounts Receivable	806.06	996.56	788.15	519.97	434.81	360.4
Other Receivables	26.64	23.57	13.09	27.85	28.08	75.42
Receivables	832.69	1,020	801.24	547.82	462.89	435.82
Inventory	2,851	2,303	1,554	1,170	931.44	826.17
Prepaid Expenses	-	-	0.95	2.59	1.98	1.86
Other Current Assets	1,583	1,890	1,993	1,109	387.04	309.93
Total Current Assets	5,468	5,480	4,789	2,895	1,809	1,628
Property, Plant & Equipment	5,894	5,746	4,632	4,029	3,389	2,799
Long-Term Investments	38.72	76.92	167.62	159.03	-	-
Other Intangible Assets	0.17	0.33	0.55	0.77	0.99	-
Long-Term Deferred Tax Assets	-	-	-	-	-	23.76
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	11,401	11,304	9,590	7,084	5,199	4,451
Accounts Payable	47.87	23.79	44.46	42.65	20.43	34.19
Accrued Expenses	455.62	444.32	298.32	245.36	185.09	161.28
Short-Term Debt	4,603	5,008	4,066	2,682	1,143	782.7
Current Portion of Long-Term Debt	111.55	35.37	18.09	28.13	18.8	71.31
Current Portion of Leases	33.25	43.55	34.72	29.25	34.62	24.13
Current Income Taxes Payable	564.09	451.2	345.48	245.11	141.44	161.28
Other Current Liabilities	319.88	288.36	47.84	14.02	28.31	8.23
Total Current Liabilities	6,135	6,295	4,855	3,287	1,572	1,243
Long-Term Debt	171.91	225.32	120.63	171.39	162.98	60.9
Long-Term Leases	51.87	64.5	89.6	100.72	131.53	27.58
Long-Term Deferred Tax Liabilities	173.97	158.01	152.11	42.36	28.25	17.3
Other Long-Term Liabilities	-	-	0	-	-0	-
Total Liabilities	6,533	6,743	5,217	3,601	1,895	1,349
Common Stock	1,074	1,074	1,074	802.3	802.3	0.8
Additional Paid-In Capital	448.17	448.17	448.17	-	-	-
Retained Earnings	1,036	708.02	443.03	204.24	535.83	1,135
Comprehensive Income & Other	2,310	2,331	2,407	2,477	1,966	1,966
Shareholders' Equity	4,868	4,561	4,372	3,483	3,304	3,102
Total Liabilities & Equity	11,401	11,304	9,590	7,084	5,199	4,451
Total Debt	4,972	5,377	4,329	3,012	1,491	966.62
Net Cash (Debt)	-4,733	-5,032	-3,721	-2,786	-1,466	-911.9
Net Cash Per Share	-44.06	-46.85	-37.42	-34.73	-18.27	-11.37
Filing Date Shares Outstanding	107.42	107.42	107.42	80.23	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	107.42	80.23	80.23	80.23
Working Capital	-667.88	-814.39	-65.55	-391.14	237.08	385.38
Book Value Per Share	45.32	42.46	40.71	43.41	41.19	38.67
Tangible Book Value	4,868	4,561	4,372	3,482	3,303	3,102
Tangible Book Value Per Share	45.31	42.46	40.70	43.40	41.17	38.67
Land	-	2,483	2,483	2,483	2,483	2,474
Buildings	-	1,415	1,142	745.82	231.9	185.08
Machinery	-	1,708	985.02	831.81	789.03	539.94
Construction In Progress	740.38	931.72	614.67	403.01	159.04	-

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.